Purchase Order HT942525PE022
Award Date 9/17/25
Potential Completion Date 9/16/30
Potential Value $167K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Germantown, MD, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award is for the provision of Ingenuity Pathway Analysis (IPA) software licenses to the Walter Reed Army Institute of Research (WRAIR), a component of the Defense Health Agency. The $168,598.05 firm-fixed-price purchase order was awarded to Qiagen, LLC, a subsidiary of the international biotechnology company Qiagen N.V. The software will be used to support genomics, transcriptomics, epigenomics, and metabolomics analysis and interpretation for various mission-critical...
- This is a firm fixed-price purchase order contract award by the U.S. Army Corps of Engineers (USACE) to Qiagen, LLC, a division of the international biotechnology company Qiagen N.V. The $90,325.61 contract is for a 1-year software license for the Ingenuity Pathways Analysis (IPA) system, which supports biomedical research, public health, and healthcare programs. The contract was awarded on a sole-source basis without any set-aside designations. Qiagen provides a variety of molecular diagnostics...
- This is a sole-source federal purchase order contract awarded by the United States Army Medical Research Acquisition Activity (USAMRAA) to Qiagen, LLC, a foreign-owned, for-profit manufacturer of molecular diagnostics, laboratory equipment, and bioinformatics software. The $131,518 firm-fixed-price contract is for the Qiagen Ingenuity Pathway Analysis (IPA) software, which is required by the U.S. Army Medical Research Institute for Infectious Diseases (USAMRIID) to analyze gene expression,...
- This is a firm fixed-price purchase order contract awarded by a civilian federal agency to Qiagen, LLC, a division of the international biotechnology company Qiagen N.V. The contract is for a Qiagen Ingenuity Pathway Analysis (IPA) Limited Concurrent License, which is used to identify and predict master regulators that may have otherwise been overlooked, and to quickly understand diseases, phenotypes, associated genes, and other relevant insights. The contract has a ceiling value of $39,252.00...
- This is a firm-fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, to Qiagen, LLC. The contract is for 4 annual licenses of Qiagen's IPA (Ingenuity Pathway Analysis) advanced analytics software, with a total ceiling value of $99,750.00. The contract does not have a set-aside designation. Qiagen is an international provider of sample and assay technologies, and has...
- This is a firm fixed-price purchase order awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a civilian agency within the U.S. Department of Health and Human Services, to Qiagen, LLC for software licenses for NIDDK's IPA (Ingenuity Pathway Analysis) software. The contract has a ceiling value of $31,733.00 and a period of performance through September 28, 2025. Qiagen is a global provider of molecular diagnostics, applied testing, and bioinformatics...
- The Department of Health and Human Services' National Institutes of Health National Institute of Environmental Health Sciences awarded a $192,095.00 firm fixed price purchase order to Qiagen, LLC to provide 5 software support license renewals for Ingenuity Pathway Analysis (IPA) software. The contract has a completion date of December 31, 2022 and does not have a set-aside designation. Qiagen, LLC is a division of the international provider Qiagen N.V., which has a history of providing a range...
- This is a $573,796.56 firm fixed-price purchase order awarded by the U.S. Army Medical Command (MEDCOM) to Qiagen, LLC, a division of Qiagen N.V., for an "IPA W/ADVANCED ANALYTICS LCL SOFTWARE." The contract has an ultimate completion date of July 26, 2021 and was awarded on July 27, 2016. There is no set-aside designation mentioned. Qiagen is an international biotechnology company that provides sample and assay technologies for molecular diagnostics, applied testing, pharma, and...
- This federal contract award is for the renewal of Qiagen's Ingenuity Pathway Analysis (IPA) software by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a component of the Department of Health and Human Services. The $23,816 firm fixed-price purchase order has a completion date of September 22, 2022. Qiagen, a multinational biotechnology company, is the prime contractor. This award is not associated with a set-aside program. Qiagen has provided a range of products...
- The Department of Health and Human Services National Institutes of Health National Human Genome Research Institute awarded a firm fixed-price purchase order to Qiagen, LLC, a division of the international provider Qiagen N.V., to provide IPA (Ingenuity Pathway Analysis) Analysis Match Explorer CL software licenses. The contract has a potential value of $139,495.00 and a performance period ending on August 31, 2023. This award does not utilize any set-aside designations. Qiagen has a history of...